J&J Vaccine Linked to Extremely Rare Side-Effect

The US FDA warned yesterday that the single-shot Johnson & Johnson coronavirus vaccine has been linked in very rare instances to Guillain-Barré syndrome.
After 12.8 million J&J vaccine doses have been dispensed in the US, the agency said there have been roughly 100 initial reports of Guillain-Barré among the vaccine’s recipients. 95 of which required hospitalization, and 1 person died.
Cases of the syndrome in which “the immune system attacks the nerves” mostly emerged about 2 weeks after vaccination in men 50-years and older.
Typically, about 3,000 to 6,000 people develop the illness each year.
Officials have emphasized that COVID-19 vaccine benefits outweigh any risks.
The Washington Post

Secondary Topic
Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top